Home / Sweden / Xvivo Perfusion Aktiebolag
Xvivo Perfusion Aktiebolag
Short position disclosed on August 12, 2026.
4.91% of the capital sold short
5 disclosing funds
161 disclosures on record
SE0004840718 ISIN code
Funds holding Xvivo Perfusion Aktiebolag Titelia
Evolution of the disclosed total
0%2%4%6%8%
Oct 2025Jan 2026Apr 2026Jul 2026
August 3, 2022 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Marchant MC Ltd | 1.57% | +0.84 pt | May 8, 2026 | |
| JPMorgan Asset Management (UK) Ltd | 1.36% | +0.04 pt | July 16, 2026 | |
| Citadel Advisors LLC | 0.89% | +0.08 pt | August 12, 2026 | |
| D E Shaw Co LP | 0.59% | -0.06 pt | April 21, 2026 | |
| ActusRayPartners Limited | 0.50% | new | May 12, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 23, 2025 | JPMorgan Asset Management (UK) Ltd | 0.93% | still open |
| June 18, 2025 | Citadel Advisors LLC | 0.63% | still open |
| June 11, 2025 | Citadel Advisors LLC | 0.51% | still open |
| April 8, 2025 | JPMorgan Asset Management (UK) Ltd | 0.80% | still open |
| April 7, 2025 | JPMorgan Asset Management (UK) Ltd | 0.67% | still open |
| April 4, 2025 | JPMorgan Asset Management (UK) Ltd | 0.55% | still open |
| July 26, 2024 | Franklin Templeton Investment Management Limited | 0.51% | still open |
| April 19, 2024 | JPMorgan Asset Management (UK) Ltd | 0.58% | still open |
| April 12, 2024 | JPMorgan Asset Management (UK) Ltd | 0.68% | still open |
| February 19, 2024 | JPMorgan Asset Management (UK) Ltd | 0.71% | still open |
| August 3, 2022 | JPMorgan Asset Management (UK) Ltd | 0.51% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
- Elekta AB (publ) 10.19% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Embracer Group AB 5.25% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Dynavox Group AB 4.30% of the capital sold short
- RaySearch Laboratories AB (publ) 4.15% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- Stillfront Group AB (publ) 3.75% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Xvivo Perfusion Aktiebolag, source Finansinspektionen, data as at August 12, 2026, https://www.quivad.com/action/xvivo-perfusion-aktiebolag?page=4